Sandip is a scientist and researcher at John Snow India
TB MAC’s main decision-making body is its Steering Committee.
Sandip Mandal
Surabhi Pandey
Surabhi is a TB modeller and researcher at Public Health Foundation India.
Sarika Mehra
Sarika is a Professor in Chemical Engineering at the Indian Institute of Technology Bombay.
Puneet Dewan
Puneet is a Senior Programme Manager at the Bill and Melinda Gates Foundation.
Lauren Brown
Lauren is a a Junior Researcher and transmission modeller at SACEMA (South African Centre for Epidemiological Modelling and Analysis), where she is completing a PhD.
Amit Summan
Amit is a Postdoctoral Fellow at the One Health Trust. His research primarily focuses on how low- and middle-income countries can improve child and maternal health outcomes through more efficient and equitable redistribution of public resources.
Nimalan Arinaminpathy
Nim is a Professor in Mathematical Epidemiology in the Imperial College School of Public Health and a Senior Epidemiologist in the TB Monitoring and Evaluation group in the WHO Global TB Programme.
Carel Pretorius
Carel is a senior analyst and modeller at Avenir Health, where he leads the development and implementation of several models in Spectrum.
Sourya Shrestha
Sourya is an assistant scientist and epidemiologist at Johns Hopkins Bloomberg School of Public Health. He develops mathematical and computational models of epidemiology of infectious diseases, ultimately to use these to design and inform effective public health interventions.
Leigh Johnson
Leigh is an epidemiologist and actuary, working at the Centre for Infectious Disease Epidemiology and Research (University of Cape Town). His research interests are in modelling of HIV and other infectious diseases, and most of his published work has focused on evaluating the impact of HIV prevention and treatment programmes in South Africa. He is the lead developer of the Thembisa model, a combined HIV and demographic model developed for South Africa.
Sedona Sweeney
Sedona is a health economist, with a research focus on economic evaluation in low- and middle-income settings. Her particular interest is in the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV
Pete Dodd
Pete is a professor of mathematical modelling and epidemiology at the School of Health and Related Research (ScHARR), University of Sheffield, UK. He currently holds a career development award fellowship from the UK Medical Research Council.
Kathy Fiekert
Kathy is a Senior TB Consultant with over 27 years’ experience in the design, implementation, management and evaluation of infectious disease control programmes for the NGO, local government, and donor sector in developing countries (mainly in conflict and post-conflict situations.) Her main areas of interest are linking community engagement, patient centeredness, human rights, and ethics to Health System Strengthening (HSS), and designing innovative approaches to optimising TB care utilising new technologies. At KNCV she is the technical lead on the Patient-Centred Framework, Strategic Planning and Stigma Reduction, and provides technical support to country and NGO TB programmes.
Richard White
Richard is Professor of Infectious Disease Modelling in the Centre for the Mathematical Modelling of Infectious Diseases and the TB Centre at the London School of Hygiene and Tropical Medicine. He leads the LSHTM TB Modelling Group. His research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV.
David Dowdy
David is an Associate Professor at Johns Hopkins University, in the Bloomberg School of Public Health. He is an epidemiologist and practising general internist whose research merges expertise in classical epidemiology, economic evaluation, infectious disease modelling, and translation of science into policy. Other interests include heterogeneity in TB transmission, active TB case-finding, development of “user-friendly” modelling tools for TB, costing of HIV prevention interventions, and evaluation of TB therapeutics and vaccines.
Finn McQuaid
Finn is an Associate Professor in Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine, and the TB MAC Secretariat Epidemiologist. His research focuses on multi-drug resistant TB, treatment adherence, and the impact of COVID-19 on TB. He has previously worked on global food security and the spatially explicit control of epidemics in sub-Saharan Africa.
Anna Bershteyn
Anna is a Senior Research Manager of the HIV/TB center at the Institute for Disease Modeling, and an Affiliate Assistant Professor of Global Health at the University of Washington. Her modelling research focuses on HIV transmission dynamics and impact evaluation of biomedical and programmatic improvements to HIV care and prevention.
Nick Menzies
Nick is an Assistant Professor of Global Health at the Harvard Chan School of Public Health, and faculty of the Harvard Center for Health Decision Science. He uses decision science and quantitative research to understand the consequences of major policy change, and help design effective disease control programs where resources are limited. His research combines empirical data with mathematical modeling to examine infectious disease control policy in high burden settings, currently focusing on the intersection of HIV and TB epidemics in sub-Saharan Africa and other high-burden settings.
Previous Members
Jason Madan
Jason is a Professor in Health Economics at Warwick Medical School, and Director of Graduate Research Studies for the School. His research involves the application of economic methods to health technology assessment in a wide range of clinical settings, including tuberculosis. He is particularly interested in the use of decision modelling and Bayesian methods to inform health policy.
Chris Dye
Chris is a Director of Strategy in the Office of the Director General at the World Health Organisation, and a Visiting Professor of Zoology at the University of Oxford. His research has focused on the large-scale dynamics of tuberculosis, HIV/AIDS, malaria, Ebola and other infectious diseases. Amongst other topics, he has investigated the rise of tuberculosis linked to HIV/AIDS in Sub-Saharan Africa, and the spread and containment of antimicrobial resistance.
Anna Vassall
Anna is a Professor of Health Economics at the London School of Hygiene and Tropical Medicine. She leads the economic evaluation and priority setting group in the Department of Global Health at LSHTM and as part of the Centre for Health Economics in London (CHIL). She specialises in the economics of HIV, sexual and reproductive health, gender based violence prevention and tuberculosis (TB).
Ted Cohen
Ted is an Associate Professor at the Yale School of Public Health. He is an infectious disease epidemiologist with a primary research focus on tuberculosis. He is particularly interested in understanding how TB drug-resistance and medical comorbidities such as HIV frustrate current efforts to control epidemics, with an ultimate goal of developing more effective approaches to limit the morbidity caused by this pathogen.
James Trauer
James is a Senior Lecturer at Monash University, where he is Head of the Epidemiological Modelling Unit at the School of Public Health and Preventive Medicine. He undertakes research to improve the effectiveness of infectious disease control programs through modelling, with a particular focus on tuberculosis (TB) and emerging infections. He also coordinates the School’s growing focus on modelling of non-communicable diseases and demographic trends and works clinically as a respiratory, sleep and general physician, undertaking regular care for TB patients at the Royal Melbourne Hospital.
Philip Welkhoff
Philip is the Malaria Program Director at the Bill and Melinda Gates Foundation. Previously, he served as director of research at the Institute for Disease Modeling (IDM). There, he helped develop computer simulations of malaria, polio, and other disease transmission dynamics to assist public health professionals and other scientists in planning the eradication of different diseases. Philip received a Special Achievement Award by a Hertz Fellow in 2009 for his work on malaria modeling.
Martien Borgdorff
Martien is Professor of Epidemiology at the University of Amsterdam and works as a senior consultant at the KNCV Tuberculosis Foundation. His main interests are the epidemiology and control of infectious diseases with a special interest in tuberculosis and HIV. His tuberculosis research focused on the molecular epidemiology of tuberculosis in low and high incidence settings and on disease burden estimates and their trends.
Michael Kimerling
Michael is the director of the Technical Services Division at KNCV Tuberculosis Foundation, covering TB program support, implementation research and policy development. He has particular interests in product adoption and evaluation of innovation in delivery.
Damian Walker
Damian is a Senior Program Officer at the Bill & Melinda Gates Foundation, where he works on the cost-effectiveness of health interventions and technologies. His portfolio of grants includes efforts to set disease control priorities globally, as well as assessments of the cost-effectiveness of new vaccines, and HIV treatment and prevention interventions at the national level.
Hsien-Ho Lin
Hsien-Ho is an associate professor at the National Taiwan University and models policy and new diagnostic tuberculosis control and prevention interventions. His research focus is the risk-factors of tuberculosis using population-based cohort and metanalysis.
Frank Cobelens
Frank is a Professor of Global Health at the University of Amsterdam, Chair of the Executive board of AIGHD and a Scientific Advisor at KNCV Tuberculosis Foundation. His scientific interest is in multidisciplinary approaches to problems at the interface of biomedical aspects of infectious diseases, socioeconomic context and control policy.
David Wilson
David is a Senior Program Officer in Decision Sciences at the Bill and Melinda Gates Foundation, Professor of Modeling & Health Economics at the Burnet Institute, and founder of the Optima Consortium for Decision Science. His dominant focus was on allocative efficiency for major infectious diseases (with a special focus on HIV).
Geoff Garnett
Geoff is a Deputy Director of Global Development and Global Health at the Bill and Melinda Gates Foundation. He works on improving the efficiency and effectiveness of health programs, with a particular focus on HIV. Prior to the foundation, he was a professor in the Department of Infectious Disease Epidemiology at Imperial College London and a Reader at Oxford University working on the epidemiology, evolution and control of sexually transmitted infections. He has served as chair of the UNAIDS Reference Group on Estimates Models and Projections and on a number of Institute of Medicine and Wellcome Trust panels.